FLUDEOXYGLUCOSE F-18 + PIFLUFOLASTAT F-18 + GOZETOTIDE for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jun 2017: Trial registered, NCT03181867
  2. 3 Aug 2017: Trial started, NCT03181867

The trials

NCT03181867: 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

State
Under way
Phase
Phase 2
People
385 taking part
Started
3 Aug 2017
Primary completion
1 Feb 2031
Arms
2/biochemical recurrence (bcr)
Results
None posted
  1. 9 Jun 2017: Trial registered
  2. 3 Aug 2017: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.